Vanguard reports 6.73 million Alnylam (ALNY) shares, putting its passive stake above 5%.
Vanguard reports 6.73 million Alnylam (ALNY) shares, putting its passive stake above 5%. Stock Titan
Covered in this story
Call it yourself
No calls on $ALNY yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Alnylam Pharmaceuticals →Dalsna Finance is currently tracking 49 stories mentioning Alnylam Pharmaceuticals, the earliest published 16 May 2017.
Summary aggregated from Stock Titan's public RSS feed. The full reporting belongs to Stock Titan — please read it on their site.